A great resource for long haulers that can lead to personalized treatment plans: www.covidlonghaulers.com
1. Maraviroc
https://clinicalinfo.hiv.gov/en/drugs...
2. Maraviroc in Patients With Moderate and Severe COVID-19
https://clinicaltrials.gov/ct2/show/N...
3. IncellDx to Study Maraviroc, a CCR5 antagonist, in a COVID-19 Phase 2 Clinical Trial
https://www.biospace.com/article/rele...
4. Large clinical trial to study repurposed drugs to treat COVID-19 symptoms
https://www.nih.gov/news-events/news-...
Warnings and Precautions for Maraviroc:
Use caution when administering Maraviroc to patients with pre-existing liver dysfunction or who are co-infected with viral hepatitis B or C.
More cardiovascular events including myocardial ischemia and/or infarction were observed in patients who received Maraviroc. Use with caution in patients at increased risk of cardiovascular events.
—
Dr. Mark White
Gateway Health and Wellness Center
Columbus, OH
www.gateway.healthcare
Follow us on Facebook at:
/ 196183807087646